Trial intelligence / Profile preview

Hyaluronic Acid vs Dapoxetine for Premature Ejaculation

NCT06451406Completed

Sponsor
New Valley University
Start
Oct 2022
Primary completion
Jun 2023
Modality
Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised trial of hyaluronic acid in premature ejaculation (PE) (2 arms), sponsored by New Valley University. Primary endpoint: Intravaginal Ejaculation Latency Time at 6 months. Started Oct 2022; status: completed.

02

Drugs

hyaluronic acid
03

Conditions

premature ejaculation (PE)

Beyond the preview

Go deeper on NCT06451406.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06451406.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call